Positive and negative AIT trials: What makes the difference?

DiscussionA  clinical trial aims to evaluate the efficacy of an agent. However, studies with potential effective compounds may fail because of methodical issues. Sometimes, they are the cause of discrepancies between successful phase II and unsuccessful phase III trials. To understand more about failure of s tudies, investigators and editors should be encouraged to publish negative trials.
Source: Allergo Journal International - Category: Allergy & Immunology Source Type: research